BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$760M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$379M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$333M |
| 5 |
Microsoft
MSFT
|
+$310M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$197M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$112M |
| 3 |
Thomson Reuters
TRI
|
+$106M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$96.1M |
| 5 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 9.53% |
| 4 | Communication Services | 9.5% |
| 5 | Consumer Discretionary | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INWK
3001
DELISTED
InnerWorkings, Inc.
INWK
| $61.1K | ﹤0.01% |
5,427
-2,063
| -28% | -$22.8K |
|
3002
CALL
Trip.com Group
TCOM
$28.3B
| $61K | ﹤0.01% |
+244
| New | +$13.2K |
|
3003
Horizon Bancorp
HBNC
$1.05B
| $60.8K | ﹤0.01% |
3,126
-258
| -8% | -$4.54K |
|
|
LJPC
3004
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $60.4K | ﹤0.01% |
1,736
-116
| -6% | -$3.73K |
|
3005
Farmers & Merchants Bancorp
FMAO
$486M
| $60.3K | ﹤0.01% |
1,654
+724
| +78% | +$23.5K |
|
3006
PUT
Regions Financial
RF
$27B
| $60.2K | ﹤0.01% |
2,853
+1,000
| +54% | +$14.4K |
|
|
RXDX
3007
DELISTED
Ignyta, Inc.
RXDX
| $60.2K | ﹤0.01% |
4,874
-184
| -4% | -$1.9K |
|
|
APTS
3008
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $60.2K | ﹤0.01% |
3,186
-490
| -13% | -$8.6K |
|
3009
Stoneridge
SRI
$201M
| $60.1K | ﹤0.01% |
3,032
-1,613
| -35% | -$26.7K |
|
|
SNC
3010
DELISTED
State National Companies, Inc.
SNC
| $60K | ﹤0.01% |
2,860
-275
| -9% | -$5.57K |
|
3011
Martin Midstream Partners
MMLP
$89.6M
| $60K | ﹤0.01% |
+3,859
| New | +$68K |
|
3012
TG Therapeutics
TGTX
$7.34B
| $60K | ﹤0.01% |
5,060
-321
| -6% | -$3.66K |
|
|
PRTK
3013
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $59.9K | ﹤0.01% |
2,386
-145
| -6% | -$3.38K |
|
3014
CALL
iShares Silver Trust
SLV
$31.3B
| $59.8K | ﹤0.01% |
6,206
+1,306
| +27% | +$20.8K |
|
3015
Ring Energy
REI
$349M
| $59.8K | ﹤0.01% |
4,125
-287
| -7% | -$3.7K |
|
3016
NeoGenomics
NEO
$2.11B
| $59.6K | ﹤0.01% |
5,353
-423
| -7% | -$4.12K |
|
|
UN
3017
DELISTED
Unilever NV New York Registry Shares
UN
| $59.6K | ﹤0.01% |
1,009
| – | – |
|
3018
Icon
ICLR
$12.9B
| $59.6K | ﹤0.01% |
+523
| New | +$55.6K |
|
3019
Zillow
ZG
$8.15B
| $59.5K | ﹤0.01% |
1,483
-16
| -1% | -$677 |
|
3020
PennyMac Financial
PFSI
$4.13B
| $59.5K | ﹤0.01% |
3,343
+344
| +11% | +$5.93K |
|
3021
Titan Machinery
TITN
$420M
| $59.4K | ﹤0.01% |
3,826
-741
| -16% | -$12K |
|
|
RVNC
3022
DELISTED
Revance Therapeutics, Inc.
RVNC
| $59.3K | ﹤0.01% |
2,153
-148
| -6% | -$3.59K |
|
|
AAIC
3023
DELISTED
Arlington Asset Investment Corp.
AAIC
| $59.3K | ﹤0.01% |
4,658
-1,246
| -21% | -$16.4K |
|
|
DHIL
3024
DELISTED
Diamond Hill
DHIL
| $59.2K | ﹤0.01% |
279
-37
| -12% | -$7.31K |
|
3025
Northeast Bank
NBN
$1.16B
| $58.9K | ﹤0.01% |
2,254
-1,006
| -31% | -$22K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2017 Portfolio in Review
As of Q3 2017, BNP Paribas Financial Markets held 4,406 positions worth $40.9B, up 23% from $33.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BNP Paribas Financial Markets deployed $6.04B of net new capital in Q3 2017, opening 160 new positions and adding to 1,683 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 250,000 shares worth $44.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $197M trimmed.
- BNP Paribas Financial Markets's largest Q3 2017 buy was iShares Russell 2000 Growth ETF: 250,000 shares worth $44.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $1.03B increase.
- BNP Paribas Financial Markets's biggest Q3 2017 reduction was Berkshire Hathaway Class B, cutting an estimated $197M.
- BNP Paribas Financial Markets fully exited Reynolds American Inc in Q3 2017, selling an estimated $96.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 24% of its $40.9B portfolio in Q3 2017.
- BNP Paribas Financial Markets opened 160 new positions and closed 164 in Q3 2017.
- BNP Paribas Financial Markets's portfolio value rose 23% quarter-over-quarter to $40.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2017, filed 3 Nov 2017.